Affordable Access

Publisher Website

Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP

Authors
Journal
Biochemical and Biophysical Research Communications
0006-291X
Publisher
Elsevier
Publication Date
Volume
324
Issue
1
Identifiers
DOI: 10.1016/j.bbrc.2004.09.047
Keywords
  • Advanced Cancers
  • Liver/Colon Cancer
  • Cancer Therapy
  • 3-Bromopyruvic Acid
  • Atp Depletion
Disciplines
  • Design

Abstract

Abstract A common feature of many advanced cancers is their enhanced capacity to metabolize glucose to lactic acid. In a challenging study designed to assess whether such cancers can be debilitated, we seeded hepatocellular carcinoma cells expressing the highly glycolytic phenotype into two different locations of young rats. Advanced cancers (2–3 cm) developed and were treated with the alkylating agent 3-bromopyruvate, a lactate/pyruvate analog shown here to selectively deplete ATP and induce cell death. In all 19 treated animals advanced cancers were eradicated without apparent toxicity or recurrence. These findings attest to the feasibility of completely destroying advanced, highly glycolytic cancers.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Advanced cancers: eradication in all cases using 3...

on Biochemical and Biophysical Re... Nov 05, 2004

[Trial hormone therapy of advanced breast cancers...

on La semaine des hôpitaux : org... 1974

[Chemoradiation therapy for advanced esophageal ca...

on Gan to kagaku ryoho. Cancer &... August 1999
More articles like this..